Dementia laboratory findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Template:Dementia}} | {{Template:Dementia}} | ||
{{CMG}} | {{CMG}} | ||
=== Electrolyte and Biomarker Studies === | ==Overview== | ||
* [[Electrolyte]]s | |||
Limited laboratory testing is recommended in most patients being evaluated for cognitive impairment and dementia. We do not order other laboratory tests unless there is a specific suspicion for abnormality. Other than the routine lab work for dementia, other laboratory tests are not recommended unless there is a specific suspicion for abnormality.<ref name="pmid7595679">{{cite journal |vauthors=Weytingh MD, Bossuyt PM, van Crevel H |title=Reversible dementia: more than 10% or less than 1%? A quantitative review |journal=J Neurol |volume=242 |issue=7 |pages=466–71 |date=July 1995 |pmid=7595679 |doi=10.1007/BF00873551 |url=}}</ref><ref name="pmid16476810">{{cite journal |vauthors=Knopman DS, Petersen RC, Cha RH, Edland SD, Rocca WA |title=Incidence and causes of nondegenerative nonvascular dementia: a population-based study |journal=Arch Neurol |volume=63 |issue=2 |pages=218–21 |date=February 2006 |pmid=16476810 |doi=10.1001/archneur.63.2.218 |url=}}</ref> | |||
==Laboratory Findings== | |||
Routine lab work for dementias include: | |||
*[[Complete blood count]] ([[CBC]]) | |||
*Toxicology screening | |||
*[[Liver function test]]s ([[LFT]]s) | |||
*[[Calcium]] | |||
*[[Blood urea nitrogen]] ([[BUN]]) / [[creatinine]] | |||
*[[Glucose]] | |||
*[[Thyroid function test]]s | |||
*[[Vitamin B12]] levels<ref name="pmid11342678">{{cite journal |vauthors=Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC |title=Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology |journal=Neurology |volume=56 |issue=9 |pages=1143–53 |date=May 2001 |pmid=11342678 |doi=10.1212/wnl.56.9.1143 |url=}}</ref> | |||
*[[Folate]] levels | |||
*Infectious/inflammatory screenings | |||
*[[HIV test]]ing for suspected patients | |||
*[[Rapid plasma reagin]] (RPR) testing for those patients suspected of having [[syphilis]] | |||
===Electrolyte and Biomarker Studies=== | |||
*[[Electrolyte]]s | |||
==References== | ==References== | ||
Latest revision as of 15:25, 9 October 2020
|
Dementia Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Limited laboratory testing is recommended in most patients being evaluated for cognitive impairment and dementia. We do not order other laboratory tests unless there is a specific suspicion for abnormality. Other than the routine lab work for dementia, other laboratory tests are not recommended unless there is a specific suspicion for abnormality.[1][2]
Laboratory Findings
Routine lab work for dementias include:
- Complete blood count (CBC)
- Toxicology screening
- Liver function tests (LFTs)
- Calcium
- Blood urea nitrogen (BUN) / creatinine
- Glucose
- Thyroid function tests
- Vitamin B12 levels[3]
- Folate levels
- Infectious/inflammatory screenings
- HIV testing for suspected patients
- Rapid plasma reagin (RPR) testing for those patients suspected of having syphilis
Electrolyte and Biomarker Studies
References
- ↑ Weytingh MD, Bossuyt PM, van Crevel H (July 1995). "Reversible dementia: more than 10% or less than 1%? A quantitative review". J Neurol. 242 (7): 466–71. doi:10.1007/BF00873551. PMID 7595679.
- ↑ Knopman DS, Petersen RC, Cha RH, Edland SD, Rocca WA (February 2006). "Incidence and causes of nondegenerative nonvascular dementia: a population-based study". Arch Neurol. 63 (2): 218–21. doi:10.1001/archneur.63.2.218. PMID 16476810.
- ↑ Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC (May 2001). "Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology". Neurology. 56 (9): 1143–53. doi:10.1212/wnl.56.9.1143. PMID 11342678.